Atlas Health, a Las Vegas, Nevada-based healthtech company providing AI-powered patient affordability solutions, has received a strategic growth investment from healthcare-focused private equity firm InTandem Capital Partners.
The transaction was announced on October 29, 2026. Financial terms were not disclosed. Atlas Health’s existing management team will continue to lead the business and retain a significant ownership stake alongside InTandem.
Founded in 2017 and led by founder and CEO Ethan Davidoff, Atlas Health develops technology that helps hospitals and health systems connect patients with healthcare coverage and financial assistance programs.
The company’s platform uses its proprietary agentic AI technology, Ava, to automate processes involved in identifying financial assistance opportunities, determining eligibility and enrolling patients in relevant programs. Its services support healthcare financial clearance, reimbursement workflows, medication access and patient assistance.
Atlas Health combines AI-powered workflow automation with patient advocates to help healthcare providers manage financial assistance processes and reduce administrative complexity.
The investment will support Atlas Health’s product development initiatives and further expansion of its services for healthcare providers and patients. The company also plans to extend its patient affordability infrastructure to specialty pharmacies, expanding its technology beyond existing hospital and health system workflows.
InTandem Capital Partners invests in healthcare services businesses and provides operational support to its portfolio companies.
J.P. Morgan served as exclusive financial advisor to Atlas Health, while Cooley LLP acted as its legal counsel. Greenberg Traurig LLP represented InTandem Capital Partners in the transaction.
